• July 2, 2013
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS), formerly the animal health business unit of Pfizer Inc., announced plans to expand its manufacturing facility in Lincoln, Neb., to facilitate the production of high-quality, reliable medicines for veterinarians, livestock producers and the animals under their care. A world leader in animal health, Zoetis expects this expansion to affirm its longstanding commitment to being a world-class manufacturer of animal healthmore...
  • July 1, 2013
    FLORHAM PARK, N.J., July 1, 2013 —In an effort to help strengthen educational programs that impact the future of animal agriculture research and development, Zoetis announced today a three-year Pork Research Fellowship program with the College of Veterinary Medicine at Iowa State University (ISU).  Zoetis will contribute $100,000 to support the tuition of three students who are eager to continue their education in veterinary swine research.“There is an ongoing critical need for newmore...
  • June 28, 2013
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS), formerly the animal health business of Pfizer Inc., will host a webcast and conference call at 8:30 a.m. (EDT) on Tuesday, Aug. 6, 2013. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial Officer Rick Passov will review second-quarter 2013 financial results, discuss 2013 financial guidance, and respond to questions from financial analysts during the call. Investors and themore...
  • June 24, 2013
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS), the former animal health business of Pfizer Inc. (NYSE: PFE), opens a new chapter in the company’s history today, marking its separation from Pfizer and first day as a fully independent company.“This is an historic day for Zoetis,” said Zoetis Chief Executive Officer Juan Ramón Alaix. “We are setting off on the next stage in our company’s life – pursuing our own initiatives and strategies as a fully independent company.”“I am very proud of all the Zoetis colleagues whomore...
  • June 20, 2013
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--The Board of Directors of Zoetis Inc. (NYSE: ZTS), formerly the animal health business of Pfizer Inc., has declared a third-quarter dividend payable to holders of the company’s common stock of $0.065 per share. The dividend is to be paid on Sept. 2, 2013, to holders of record on Aug. 1, 2013. About Zoetis Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses.more...
  • June 20, 2013
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--The Board of Directors of Zoetis Inc. (NYSE: ZTS), formerly the animal health business of Pfizer Inc., has declared a third-quarter dividend payable to holders of the company’s common stock of $0.065 per share. The dividend is to be paid on Sept. 2, 2013, to holders of record on Aug. 1, 2013. About Zoetis Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses.more...
  • June 6, 2013
    BANGKOK, THAILAND - Zoetis Inc., formerly the animal health business unit of Pfizer Inc., is organizing a Congress with more than  1,000 animal health industry professionals to map out a strategy that will put Thailand in the forefront of  ASEAN’s animal health sector.  Professionals involved in veterinary science, including academics, veterinarians, farm owners, professionals in the livestock sector, as well as technicians and manufacturers of equipment related to animal healthmore...
  • June 3, 2013
    WASHINGTON, D.C. – Help for the more than 12,000 children diagnosed with cancer each year in the United States, in the form of an innovative, four-legged therapy, is about to be rigorously studied to determine its efficacy. Zoetis Inc., a global leader in the advancement of animal health and wellness, and American Humane Association, which since 1877 has been the nation’s leading charity dedicated to the  welfare, wellness and well-being of children and animals, and to unleashing themore...
  • May 30, 2013
    Finding time in a hectic veterinary practice to order animal health products from Zoetis just became faster and easier, thanks to a new web-based ordering site that offers customers in the United States 24/7 access to more than 300 product lines that support the health of beef and dairy cattle, poultry, pigs, dogs, cats, horses and sheep. The new eCommerce site (www.zoetisus.com click on SHOP)—the industry’s most robust and personalizedmore...
  • May 22, 2013
    MADISON, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) announced it intends to file a Registration Statement on Form S-4 with the Securities and Exchange Commission (SEC) today in connection with the proposed exchange offer announced by Pfizer Inc. (NYSE: PFE). As part of the offer, Pfizer shareholders will be able to exchange all, some or none of their shares of Pfizer common stock for shares of Zoetis common stock. Pfizer currently holds approximately 80% of themore...